In final updated guidance published today NICE recommends a number of drugs called biological disease modifying drugs (DMARDs) as options for treating severei rheumatoid arthritis which has not ...
Pfizer is leaning heavily on Celltrion for biosimilar development and manufacturing, but its South Korean partner has stumbled with an FDA inspection that uncovered issues at its plant in Incheon. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results